Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

A prospective, multicenter, open label, randomized phase III study to evaluate efficacy and safety of FFX versus CPI-613 + mFFX in patients with metastatic adenocarcinoma of the pancreas with age range of 18 to 75 years
Not Available
III
Cardin, Dana
NCT03504423
VICCGI18158

Anetumab Ravtansine in Treating Patients with Mesothelin Positive, Locally Advanced, or Metastatic Pancreatic Cancer That Cannot Be Removed by Surgery

Pancreatic

This phase II trial studies how well anetumab ravtansine works in treating patients with mesothelin positive pancreatic cancer that has spread to other places in the body and cannot be removed by surgery. Monoclonal antibodies, such as anetumab ravtansine, may find tumor cells and help kill them.
Pancreatic
II
Cardin, Dana
NCT03023722
VICCGI1720

A Phase 2 Study of Cediranib in Combination with Olaparib in Advanced Solid Tumors

This phase II trial studies cediranib maleate in combination with olaparib in treating patients with solid tumors that have spread to other parts of the body or cannot be removed by surgery, including breast cancer, non-small cell lung cancer, small cell lung cancer, and pancreatic cancer. Cediranib maleate and olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may also block the flow of oxygen to the tumor, and may help make the tumor more sensitive to olaparib.
Not Available
II
Cardin, Dana
NCT02498613
VICCPHI1671

Avelumab in Treating Patients with Advanced or Metastatic Small Intestine Cancer

This pilot phase II trial studies the side effects of avelumab and how well it works in treating patients with small intestine cancer that has spread to other places in the body or usually cannot be cured or controlled with treatment. Monoclonal antibodies, such as avelumab, may interfere with the ability of tumor cells to grow and spread.
Not Available
II
Cardin, Dana
NCT03000179
VICCGI1679

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: